| Field | Detail |
|---|---|
| Entity profiled | Aedifica SA/NV (absorbing company of Cofinimmo SA/NV) |
| Legal form | Public limited liability company; public regulated real estate company (RREC / SIR / GVV) under Belgian law |
| Registered office / HQ | Rue Belliard 40 (box 11), 1040 Brussels, Belgium |
| Enterprise number | 0877.248.501 (RLE Brussels) |
| Incorporation | 7 November 2005, Belgium |
| Listings | Euronext Brussels (since 2006 IPO) and Euronext Amsterdam (since November 2019) |
| Ticker | AED (Euronext Brussels/Amsterdam); AOO (German venues) |
| ISIN | BE0003851681 |
| Index membership | BEL 20 (since March 2020, weighting ~4.7% at 30.06.2026), BEL ESG, EPRA Europe (~2.9% weighting), EPRA Belgium (~34.6%), GPR 250, Stoxx Europe 600 |
| Fiscal year end | 31 December |
| Shares outstanding | 92,632,604 (after 1 July 2026 merger issuance) |
| Share price (approx.) | ~EUR 62.30 (Lang & Schwarz weekend quote, 18 Oct 2026; secondary source) |
| Market capitalisation (derived) | ~EUR 5.77 bn (92.63m shares × EUR 62.30). Note: one secondary source quoted EUR 5.2 bn on 16 Oct 2026; the discrepancy likely reflects a stale share count. Company-reported market cap was EUR 5.89 bn at 30.06.2026 on 83.47m shares at EUR 70.60 |
| 52-week range | EUR 60.35 – 80.05 (secondary source, 16 Oct 2026) |
| Employees | Aedifica standalone: ~127–131 (aggregator data, pre-merger). Combined headcount after absorbing Cofinimmo's team: not publicly disclosed |
| Statutory auditor | Aedifica: not confirmed in this research (H1 2026 report contains a limited-review auditor's report; name not captured). Legacy Cofinimmo: KPMG Réviseurs d'Entreprises, represented by Jean-François Kupper (Cofinimmo FY2025 press release, 20.02.2026) |
| Website | www.aedifica.eu (legacy: www.cofinimmo.com) |
| Credit ratings | S&P: BBB+ / stable / A-2 (upgraded March 2026, reconfirmed 20 July 2026). Moody's: A3 / stable, first-time issuer rating (reported 15 Oct 2026 by secondary sources; see Section 21) |
### Legacy entity (for reference)
| Field | Detail |
|---|---|
| Legal name | Cofinimmo SA/NV |
| Enterprise number | 0426.184.049 (Brussels Register of Legal Entities) |
| Founded | 1983 |
| HQ | Avenue de Tervueren / Tervurenlaan 270, Brussels ("The Gradient" building) |
| Former listing | Euronext Brussels, ticker COFB, ISIN BE0003593044; BEL 20 constituent |
| REIT regimes | Belgian RREC, French SIIC, Dutch FBI, Spanish SOCIMI (per company and press descriptions) |
| Shares | 38,096,217 issued at 31.12.2025 |
| Market cap at 31.12.2025 | EUR 3,017 m (share price EUR 79.20) |
| Last CEO / CFO | Jean-Pierre Hanin (CEO) / Jean Kotarakos (CFO) |
| Status | Delisted 1 July 2026; absorbed by Aedifica |
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Aedifica employees (headcount) | — | 131 | 127 |
Note: 2024–2025 headcounts come from data aggregators (roic.ai, Investing.com) and are not company-verified; Cofinimmo headcount was not captured in this research.
Aedifica, following its absorption of Cofinimmo, is Europe's largest listed healthcare real estate investment trust by portfolio value. At 30 June 2026 it owned a EUR 12.5 bn portfolio of 1,723 properties, including a EUR 11.1 bn healthcare book of 924 care properties housing roughly 67,400 residents and 12,900 children across nine countries: Belgium, Germany, Finland, the UK, the Netherlands, France, Ireland, Spain and Italy. Its business model is long-lease, largely triple- or double-net rental to professional care operators, indexed to inflation, with a 15-year WAULT and 99.1% occupancy. The group carries two non-core legacy segments from Cofinimmo: Brussels offices (EUR 874 m) and the Pubstone pub portfolio leased to AB InBev (EUR 468 m). With BBB+ (S&P) and A3 (Moody's) ratings, a 1.9% average cost of debt and EUR 16 m targeted run-rate synergies, the group is positioned as the scale consolidator in a fragmented, demographically driven European care property market.
---
### What the company does
Aedifica is a specialised property investor and developer. It acquires, develops (mostly through pre-let development partnerships), owns and manages real estate used for care. It leases these assets on long-term contracts to private, non-profit and public operators. It does not provide care services itself; operating risk sits with tenants, while Aedifica bears property, re-letting, tenant-credit and valuation risk.
After absorbing Cofinimmo, the group has three reportable activity lines:
1. **Healthcare real estate** (89% of total portfolio fair value; ~88% of contractual rents at 30.06.2026). Sub-types by fair value of the total portfolio: elderly care homes 60%, mixed-use elderly care 13%, cure centres (acute, rehabilitation and psychiatric clinics) 7%, childcare centres 3%, senior housing 2%, disabled-care facilities 2%, other care 2%.
2. **Offices** (7% of fair value; EUR 874 m; 23 sites, all in Belgium, largely Brussels CBD), inherited from Cofinimmo.
3. **Distribution networks** (4% of fair value; EUR 468 m; 776 sites), mainly the Pubstone portfolio of pubs and restaurants in Belgium (577 sites) and the Netherlands (185 sites) leased to AB InBev.
Source: Aedifica 2026 Half Year Financial Report (01.09.2026).
### Business and revenue model
| Revenue dimension | Characterisation |
|---|---|
| Revenue type | ~100% rental income (lease/"subscription-like" contractual rent); minor finance-lease interest income, development interest and writeback of sold lease receivables |
| Product vs service vs licensing | No product, service or licensing revenue in the conventional sense; revenue is real-estate rent |
| Contract structure | Long leases. Triple-net (operator bears operating costs, maintenance and vacancy) typical in Belgium, UK, Ireland and Spain, and often the Netherlands and Italy. Double-net (owner keeps roof, structure and facade) typical in Germany, Finland and France |
| Indexation | Annual CPI-linked indexation, usually on the contract anniversary date. H1 2026 like-for-like rental growth of 1.7% was made up of +1.9% indexation, +0.2% reversion and contingent rents, and −0.4% FX |
| Lease duration | WAULT 15 years for total portfolio, 16 years for healthcare (30.06.2026) |
| Occupancy | 99.1% total; 99.7% healthcare (EPRA methodology, 30.06.2026) |
| Gross yield | 6.1% on fair value (healthcare 6.0%, offices 6.3%, distribution 7.4%) |
### Value-chain position
Aedifica sits between capital markets (equity, bonds, bank debt, commercial paper) and care operators. It provides long-dated real-estate capital that lets operators run asset-light models. It increasingly acts as a developer-owner: the committed investment programme was EUR 531 m at 30.06.2026, of which EUR 268 m already spent. These are mostly pre-let new builds in Finland, Spain, Ireland, Germany and the UK, with a targeted initial yield on cost of 6–6.5% (actual pipeline average 5.8% after inheriting legacy Cofinimmo Spanish projects).
### Customers and end-markets
**Customers:** About 190 tenant groups (Aedifica H1 2026). Largest exposures by contractual rent: Clariane 12%, Colisée (incl. Armonea) 7%, AB InBev 4%, Emeis 4%, DomusVi 3%, Emera 3%, Azurit Rohr 3%, Vulpia 3%, Maria Mallaband 2%, Finnish municipalities/wellbeing services counties 2%. Others account for 57%.
**End-markets:** European elderly care (dominant), childcare (Finland), disabled care, acute and rehabilitation care (France, Belgium), mental health, plus Brussels office space and Benelux hospitality (pubs).
**Ultimate demand driver:** the over-80 population in the EU and UK, which the company puts above 31 million in 2025 and expects to double to over 60 million by 2060.
### Company's own description (paraphrased)
In its latest reporting, Aedifica describes itself as a Belgian REIT focused on European healthcare property, especially elderly-care housing. It frames the Cofinimmo merger as creating Europe's leading healthcare REIT, with lower capital costs and sustainable EPS growth as the main value-creation levers (Aedifica H1 2026 report). Cofinimmo's last self-description (FY2025 release) presented it as a 40-year-old owner of care, living and working spaces under the tagline "Caring, Living and Working – Together in Real Estate", with healthcare in nine countries as its core.
### Independent characterisation
Analytically, the combined group is a pure-play European healthcare landlord with a non-core diversified tail of about 11% of portfolio value (offices plus pubs). This tail is a legacy of Cofinimmo's history as Belgium's largest diversified REIT. The investment case rests on three things:
1. Inflation-indexed, very long contractual cash flows.
2. A funding-cost advantage from investment-grade ratings and scale.
3. Disciplined capital recycling out of non-core assets.
Its key sensitivities are operator health, especially Clariane and Colisée/Armonea, together about 19% of rent; refinancing costs as legacy cheap hedges roll off; and the trading discount to NAV, which governs whether equity-funded growth is accretive.